Successful Treatment of Concurrent Follicular Lymphoma and Triple-Negative Breast Cancer Using Rituximab Plus Nab-Paclitaxel and Cisplatin: A Case Report and Literature Review

References

• Weir HK, Johnson CJ, Thompson TD. The effect of multiple primary rules on population-based cancer survival. Cancer Causes Control. 2013;24(6):1231–1242. doi:10.1007/s10552-013-0203-3
   PubMed Web of Science ®Google Scholar
• Rosso S, De Angelis R, Ciccolallo L, et al. Multiple tumours in survival estimates. Eur J Cancer. 2009;45(6):1080–1094. doi:10.1016/j.ejca.2008.11.030
   PubMed Web of Science ®Google Scholar
• Hiraoka E, Masumoto N, Furukawa T, et al. Follicular lymphoma without lymphadenopathy incidentally diagnosed by sentinel lymph node biopsy during breast cancer surgery: a case report. Surg Case Rep. 2022;8(1):167. doi:10.1186/s40792-022-01524-4
   PubMed Web of Science ®Google Scholar
• Eto R, Nakamura R, Yamamoto N, et al. Synchronous early-stage breast cancer and axillary follicular lymphoma diagnosed by core needle biopsy: a case report. Mol Clin Oncol. 2022;16(1):3. doi:10.3892/mco.2021.2436
   PubMed Web of Science ®Google Scholar
• Saleem T, Mi K, Pathak R, Yari K, Lu K. Concurrent breast carcinoma and follicular lymphoma: a case series. Am J Case Rep. 2021;22:e931772. doi:10.12659/AJCR.931772
   PubMed Web of Science ®Google Scholar
• Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008;26(8):1275–1281. doi:10.1200/JCO.2007.14.4147
   PubMed Web of Science ®Google Scholar
• Sikov WM, Berry DA, Perou CM, et al. Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance). J Clin Oncol. 2015;33(1):13–21. doi:10.1200/JCO.2014.57.0572
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen Y, Cheng M-Y, et al. Homologous recombination deficiency predicts the response to platinum-based neoadjuvant chemotherapy in early-stage triple-negative breast cancer patients: a systematic review and meta-analysis. Ther Adv Med Oncol. 2022;14:17588359221096253. doi:10.1177/17588359221096253
   Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247. doi:10.1016/j.ejca.2008.10.026
   PubMed Web of Science ®Google Scholar
• Tamaoki M, NIO Y, TSUBOI K, et al. A rare case of non-invasive ductal carcinoma of the breast coexisting with follicular lymphoma: a case report with a review of the literature. Oncol Lett. 2014;7(4):1001–1006. doi:10.3892/ol.2014.1885
   PubMed Web of Science ®Google Scholar
• Mirkheshti N, Mohebtash M. A rare case of bilateral breast lobular carcinoma coexisting with primary breast follicular lymphoma. J Community Hosp Intern Med Perspect. 2019;9(2):155–158. doi:10.1080/20009666.2019.1579611
   PubMed Web of Science ®Google Scholar
• Fushimi A, Kinoshita S, Kudo R, Takeyama H. Incidental discovery of follicular lymphoma by sentinel lymph node biopsy and skin-sparing mastectomy for Paget’s disease associated with invasive breast cancer. J Surg Case Rep. 2019;2019(1):rjz008. doi:10.1093/jscr/rjz008
   PubMedGoogle Scholar
• Papanastasopoulos P, Merchant S, Kenny L. Follicular lymphoma in a patient with previously treated early breast cancer; the role of PET imaging and repeat tissue diagnosis. Breast J. 2015;21(6):691–692. doi:10.1111/tbj.12511
   PubMed Web of Science ®Google Scholar
• Michalinos A, Vassilakopoulos T, Levidou G, Korkolopoulou P, Kontos M. Multifocal bilateral breast cancer and breast follicular lymphoma: a simple coincidence? J Breast Cancer. 2015;18(3):296–300. doi:10.4048/jbc.2015.18.3.296
   PubMed Web of Science ®Google Scholar
• Hahm MH, Kim HJ, Shin KM, et al. Concurrent invasive ductal carcinoma of the breast and malignant follicular lymphoma, initially suspected to be metastatic breast cancer: a case report. J Breast Cancer. 2014;17(1):91–97. doi:10.4048/jbc.2014.17.1.91
   PubMed Web of Science ®Google Scholar
• Laudenschlager MD, Tyler KL, Geis MC, Koch MR, Graham DB. A rare case of synchronous invasive ductal carcinoma of the breast and follicular lymphoma. S D Med. 2010;63(4):123–125.
   PubMedGoogle Scholar
• Cuff KE, Dettrick AJ, Chern B. Synchronous breast cancer and lymphoma: a case series and a review of the literature. J Clin Pathol. 2010;63(6):555–557. doi:10.1136/jcp.2009.069625
   PubMed Web of Science ®Google Scholar
• Cox J, Lunt L, Webb L. Synchronous presentation of breast carcinoma and lymphoma in the axillary nodes. Breast. 2006;15(2):246–252. doi:10.1016/j.breast.2005.06.009
   PubMed Web of Science ®Google Scholar
• Barranger E, Marpeau O, Uzan S, Antoine M. Axillary sentinel node involvement by breast cancer coexisting with B-cell follicular lymphoma in nonsentinel nodes. Breast J. 2005;11(3):227–228. doi:10.1111/j.1075-122X.2005.21697.x
   PubMed Web of Science ®Google Scholar
• Nishikawa A, Kasai H, Koyama Y, et al. Synchronous ipsilateral carcinoma of the accessory mammary gland and primary lymphoma of the breast with subsequent rectal carcinoma: report of a case. World J Surg Oncol. 2014;12(1):286. doi:10.1186/1477-7819-12-286
   PubMedGoogle Scholar
• Yi X, Lou L, Wang J, Xiong J, Zhou S. Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway. Cancer Chemother Pharmacol. 2021;87(5):647–656. doi:10.1007/s00280-021-04238-w
   PubMed Web of Science ®Google Scholar
• Watkins JA, Irshad S, Grigoriadis A, Tutt AN. Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers. Breast Cancer Res. 2014;16(3):211. doi:10.1186/bcr3670
   PubMed Web of Science ®Google Scholar
• Tung NM, Robson ME, Ventz S, et al. TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes. J Clin Oncol. 2020; 38(36):4274–4282. doi:10.1200/JCO.20.02151
   PubMed Web of Science ®Google Scholar
• Pellegrino B, Musolino A, Llop-Guevara A, et al. Homologous recombination repair deficiency and the immune response in breast cancer: a literature review. Transl Oncol. 2020;13(2):410–422. doi:10.1016/j.tranon.2019.10.010
   PubMed Web of Science ®Google Scholar